Cramer on FDA resignations in connection with approval of Biogen’s Alzheimer’s drug

About This Source - CNBC Television

CNBC is an American pay television business news channel, which primarily carries business day coverage of U.S. and international financial markets. Following the end of the business day and on non-trading days, CNBC primarily carries financial and business-themed documentaries and reality shows.

As of February 2015, CNBC is available to approximately 93,623,000 pay television households (80.4% of households with television) in the United States.

Recent from CNBC Television:

  • Azek CEO: Trends in housing support future growth
  • Viral dads take social media by storm
  • Religious leaders encourage the return of in-person services
  • CNBC Television published this video item, entitled “Cramer on FDA resignations in connection with approval of Biogen’s Alzheimer’s drug” – below is their description.

    UBS upgraded the Biogen’s stock to “buy” from “neutral” and Bernstein raised its rating to “outperform.” Both firms base their moves on the potential sales bump from the FDA’s approval this week of the biotech’s Alzheimer’s treatment. CNBC’s Jim Cramer, Carl Quintanilla and David Faber discuss.

    CNBC Television YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    Leave a Comment